Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

167 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Decreased platelet APP isoform ratios in autosomal dominant Alzheimer's disease: baseline data from a DIAN cohort subset.
Chatterjee P, Gupta VB, Fagan AM, Jasielec MS, Xiong C, Sohrabi HR, Dhaliwal S, Taddei K, Bourgeat P, Brown BM, Benzinger T, Bateman RJ, Morris JC, Martins RN; Dominantly Inherited Alzheimer Network. Chatterjee P, et al. Among authors: bourgeat p. Curr Alzheimer Res. 2015;12(2):157-64. doi: 10.2174/1567205012666150204125732. Curr Alzheimer Res. 2015. PMID: 25654503 Free PMC article.
CenTauR: Toward a universal scale and masks for standardizing tau imaging studies.
Villemagne VL, Leuzy A, Bohorquez SS, Bullich S, Shimada H, Rowe CC, Bourgeat P, Lopresti B, Huang K, Krishnadas N, Fripp J, Takado Y, Gogola A, Minhas D, Weimer R, Higuchi M, Stephens A, Hansson O, Doré V; Alzheimer's Disease Neuroimaging Initiative and the AIBL research group. Villemagne VL, et al. Among authors: bourgeat p. Alzheimers Dement (Amst). 2023 Jul 7;15(3):e12454. doi: 10.1002/dad2.12454. eCollection 2023 Jul-Sep. Alzheimers Dement (Amst). 2023. PMID: 37424964 Free PMC article.
Biostatistical Estimation of Tau Threshold Hallmarks (BETTH) Algorithm for Human Tau PET Imaging Studies.
Gogola A, Lopresti BJ, Tudorascu D, Snitz B, Minhas D, Doré V, Ikonomovic MD, Shaaban CE, Matan C, Bourgeat P, Mason NS, Aizenstein H, Mathis CA, Klunk WE, Rowe CC, Lopez OL, Cohen AD, Villemagne VL; Alzheimer’s Disease Neuroimaging Initiative. Gogola A, et al. Among authors: bourgeat p. J Nucl Med. 2023 Nov;64(11):1798-1805. doi: 10.2967/jnumed.123.265941. Epub 2023 Sep 14. J Nucl Med. 2023. PMID: 37709531 Free PMC article.
The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease.
Ellis KA, Bush AI, Darby D, De Fazio D, Foster J, Hudson P, Lautenschlager NT, Lenzo N, Martins RN, Maruff P, Masters C, Milner A, Pike K, Rowe C, Savage G, Szoeke C, Taddei K, Villemagne V, Woodward M, Ames D; AIBL Research Group. Ellis KA, et al. Int Psychogeriatr. 2009 Aug;21(4):672-87. doi: 10.1017/S1041610209009405. Epub 2009 May 27. Int Psychogeriatr. 2009. PMID: 19470201 Free article.
Relationship between atrophy and beta-amyloid deposition in Alzheimer disease.
Chételat G, Villemagne VL, Bourgeat P, Pike KE, Jones G, Ames D, Ellis KA, Szoeke C, Martins RN, O'Keefe GJ, Salvado O, Masters CL, Rowe CC; Australian Imaging Biomarkers and Lifestyle Research Group. Chételat G, et al. Among authors: bourgeat p. Ann Neurol. 2010 Mar;67(3):317-24. doi: 10.1002/ana.21955. Ann Neurol. 2010. PMID: 20373343
Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging.
Rowe CC, Ellis KA, Rimajova M, Bourgeat P, Pike KE, Jones G, Fripp J, Tochon-Danguy H, Morandeau L, O'Keefe G, Price R, Raniga P, Robins P, Acosta O, Lenzo N, Szoeke C, Salvado O, Head R, Martins R, Masters CL, Ames D, Villemagne VL. Rowe CC, et al. Among authors: bourgeat p. Neurobiol Aging. 2010 Aug;31(8):1275-83. doi: 10.1016/j.neurobiolaging.2010.04.007. Epub 2010 May 15. Neurobiol Aging. 2010. PMID: 20472326
Larger temporal volume in elderly with high versus low beta-amyloid deposition.
Chételat G, Villemagne VL, Pike KE, Baron JC, Bourgeat P, Jones G, Faux NG, Ellis KA, Salvado O, Szoeke C, Martins RN, Ames D, Masters CL, Rowe CC; Australian Imaging Biomarkers and Lifestyle Study of Ageing (AIBL) Research Group. Chételat G, et al. Among authors: bourgeat p. Brain. 2010 Nov;133(11):3349-58. doi: 10.1093/brain/awq187. Epub 2010 Aug 25. Brain. 2010. PMID: 20739349
Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease.
Villemagne VL, Pike KE, Chételat G, Ellis KA, Mulligan RS, Bourgeat P, Ackermann U, Jones G, Szoeke C, Salvado O, Martins R, O'Keefe G, Mathis CA, Klunk WE, Ames D, Masters CL, Rowe CC. Villemagne VL, et al. Among authors: bourgeat p. Ann Neurol. 2011 Jan;69(1):181-92. doi: 10.1002/ana.22248. Ann Neurol. 2011. PMID: 21280088 Free PMC article.
Independent contribution of temporal beta-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer's disease.
Chételat G, Villemagne VL, Pike KE, Ellis KA, Bourgeat P, Jones G, O'Keefe GJ, Salvado O, Szoeke C, Martins RN, Ames D, Masters CL, Rowe CC; Australian Imaging Biomarkers and Lifestyle Study of ageing (AIBL) Research Group. Chételat G, et al. Among authors: bourgeat p. Brain. 2011 Mar;134(Pt 3):798-807. doi: 10.1093/brain/awq383. Epub 2011 Feb 9. Brain. 2011. PMID: 21310725
167 results